Behavioural Intervention

PRECISE for Suicide Prevention

San Diego, CA

N/A

Waitlist Available

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 18-65 years old

Be older than 18 years old

Must not have

Lack of capacity to consent to research and/or under conservatorship.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from enrollment to the end of the follow-up assessment at 6-months.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to develop a personalized treatment for individuals at high risk of suicide called PRECISE. The treatment uses data from ecological momentary assessments and network science to tailor Safety Planning and skills from D

See full description

Who is the study for?

This trial is for adults at high risk of suicide who may benefit from a personalized intervention. Participants should be experiencing suicidal thoughts or depression and are willing to engage in an intensive study involving regular self-assessments and coaching sessions.Check my eligibility

What is being tested?

PRECISE, a novel treatment, is being tested. It uses data from frequent personal assessments to tailor suicide prevention strategies for each individual. The trial compares two versions: one with initial assessment-based tailoring and another with ongoing, more intense customization over eight weeks.See study design

What are the potential side effects?

Since PRECISE involves non-pharmacological interventions like Safety Planning and Dialectical Behavior Therapy skills coaching, traditional side effects associated with medications are not expected. However, participants might experience emotional discomfort when discussing sensitive topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot legally consent to join a study.

show original

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from enrollment to the end of the follow-up assessment at 6-months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from enrollment to the end of the follow-up assessment at 6-months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to the end of the follow-up assessment at 6-months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Scale for Suicide Ideation

Secondary study objectives

Cognitive Emotion Regulation Questionnaire

Emotion Reactivity Scale

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Low-IntensityExperimental Treatment1 Intervention

In the low intensity arm, participants will complete only an initial two weeks burst of EMA and GIMME will be run following an initial burst. A treatment plan for the next eight weeks will be generated based on the output.

Group II: High-IntensityExperimental Treatment1 Intervention

In the high intensity arm, participants will complete all eight weeks of EMA with idiographic models generated between each session. Coaches then shape selection of skills in collaboration with the patient and a treatment plan for the next session will be generated.

0 / 2Eligibility criteria met